ArticleMolecular biomedicine2026

Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling.

Tao-Ran Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.